New Scientific Report Supports the Use of Prolacta’s Neonatal Nutritional Products in Extremely Premature Infants
Type: Press Releases
Topic(s): Clinical Studies Late-Onset Sepsis Necrotizing Entercolitis (NEC)
Prolacta Introduces the Worlds First and Only Human Milk Caloric Fortifier Made from Human Milk Cream for Preemies in the NICU
Type: Press Releases
Topic(s): Clinical Studies on Prolact/Humavant CR
Prolacta Announces the First Premature Infant Formula Made from Human Milk
Type: Press Releases
Topic(s): Product Total Parenteral Nutrition (TPN) Use
Premier Global Event on Human Milk Science and Innovation Sponsored by Prolacta Bioscience
Type: Press Releases
Topic(s): Bone Marrow Transplant Clinical Studies Conferences and Events
Prolacta Makes Statement on Recent Study Demonstrating Risks of Milk Sharing
Type: Press Releases
Topic(s): Clinical Studies
Prolacta Announces the Opening of a New 67000 Square Foot Facility to Meet Growing Hospital Demand for Exclusive Human Milk Nutrition for Preemies
Type: Press Releases
Topic(s): Company
Study Determines Development of Necrotizing Enterocolitis In Premature Infants Increases Long-Term Healthcare Costs
Type: Press Releases
Topic(s): Cost Savings / Cost Effectiveness Necrotizing Entercolitis (NEC) Total Parenteral Nutrition (TPN) Use
Prolacta Bioscience to Donate the Processing of Nearly 17000 Ounces of Donor Breast Milk for International Breast Milk Project
Type: Press Releases
Topic(s): Company
Prolacta Announces Study Published in Journal of Pediatrics DemonstratesLower Incidence of Intestinal Disease in Preemies Fed Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Clinical Studies Necrotizing Entercolitis (NEC) Total Parenteral Nutrition (TPN) Use
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com
